Clostridioides difficile infection (CDI) is a major enteric disease associated with antibiotic
use and a leading cause of hospital-acquired infections worldwide. This is the first guideline …

This clinical practice guideline is a focused update on management of Clostridioides difficile
infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for …

Clostridioides difficile infection (CDI) has been an epidemic for many years. Our biggest
challenge in treating CDI is preventing recurrence, which is seen in approximately 25% of …

Purpose Clostridioides difficile infection (CDI) is a widely recognized condition associated
with comorbidity and decreased patient quality of life. Certain professional medical …

Objective: To systematically assess the current related methodological quality of guidelines
for the diagnosis and treatment of Clostridioides difficile infection (CDI), revealing the …

Clostridioides (formerly Clostridium) difficile infection (CDI) is the most common cause of
health care–associated infectious diarrhea in the developed world. The Infectious Diseases …

Background Limited data currently exist on the incidence of Clostridioides difficile infection
(CDI) in Saudi Arabia. Compliance with CDI treatment guidelines is prudent for proper …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

Clostridioides difficile infection (CDI) is the leading cause of health care–associated
infections in the United States. The increasing incidence and recurrence rates of CDI …

Guidelines for the diagnosis and treatment of Clostridioides difficile infection have recently
been updated. Risk factors include recent exposure to health care facilities or antibiotics …